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Abstract Transcription is one of the most fundamental
nuclear functions and is an enzyme complex-mediated
reaction that converts DNA sequences into mRNA. Ana-
lyzing DNA sequences of 50-ﬂanking regions of several
human genes that respond to 12-O-tetradecanoyl-phorbol-
13-acetate (TPA) in HL-60 cells, we have identiﬁed that
the ets (GGAA) motifs are duplicated, overlapped, or
clustered within a 500-bp distance from the most
50-upstream region of the cDNA. Multiple protein factors
including Ets family proteins are known to recognize and
bind to the GGAA containing sequences. In addition, it has
been reported that the ets motifs play important roles in
regulation of various promoters. Here, we propose a
molecular mechanism, deﬁned by the presence of dupli-
cation and multiplication of the GGAA motifs, that is
responsible for the initiation of transcription of several
genes and for the recruitment of binding proteins to the
transcription start site (TSS) of TATA-less promoters.
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Abbreviations
ATRA All-trans retinoic acid
bp Base pair
IFN Interferon
iPS cells Induced pluripotent stem cells
ISRE Interferon-stimulated response element
Luc Luciferase
MCS Multi-cloning site
nt Nucleotide(s)
PARG Poly(ADP-ribose) glycohydrolase
PD-1 Programmed death-1
TBP TATA-binding protein
TPA 12-O-tetradecanoyl-phorbol-13-acetate
TSS Transcription start site
Introduction
A human promyelocytic cell line, HL-60, is frequently
used to analyze cellular differentiation mechanisms
[1]. HL-60 cells differentiate into macrophage-like
cells and granulocytic cells after treatments with
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12312-O-tetradecanoyl-phorbol-13-acetate (TPA) and all-trans
retinoic acid (ATRA), respectively [1–3]. In particular, it
has been shown that the expression of a number of genes is
augmented during differentiation induced by TPA [4].
Recently, TPA was successfully administered to patients
with myelocytic leukemia, leading to temporary remission
[5, 6]. This TPA-treatment is based on a concept that the
growth and proliferation of lymphoma or cancer cells could
be artiﬁcially suppressed if they are forced to differentiate
into a non-growing state [7]. However, TPA has been
originally identiﬁed as a cancer-causing reagent (carcino-
gen) activating protein kinase C [1]. Therefore, extreme
care will be needed to administer the reagent in clinical
situations.
It has been demonstrated that somatic cells could be
converted into induced pluripotent stem (iPS) cells by
introducing just four transcription factors, namely Oct4,
Sox2, Klf4, and c-Myc expression vectors or their encoding
proteins, into somatic cells [8, 9]. The possibility to change
the destiny of cells by introducing transcriptional factors
prompted us to study transcription systems that control
cellular differentiation. In order to establish a method to
convert malignant cells to the non-growing differentiated
state without using TPA, it will be important to determine
and characterize molecular mechanisms in the transcrip-
tional signal transduction systems that are induced by
TPA. In other words, the changes in the TPA-induced
transcriptional controlling system will provide useful
information about which genes of transcription factors
should be transfected into the malignant cells.
Previously, it has been demonstrated that the human
PARG promoter is activated during the differentiation of
HL-60 cells induced by TPA [10]. Another example is the
IGHMBP2 promoter, whose cDNA was isolated by South-
Western screening during a search for a gene encoding a
binding factor to a 50-bp sequence of the MMTV LTR
[11]. Interestingly, there are no obvious TATA- or
CCAAT-boxes around the transcription start sites (TSS),
but the duplicated GGAA motifs are commonly contained
in the region between the TSS and the 100-bp upstream of
the human PARG and IGHMBP genes. In addition, muta-
tion analyses showed that the duplicated GGAA motifs of
both promoters play a primarily important role in promoter
activity during the TPA-response [10, 12]. Taken together,
the duplicated (overlapped) GGAA motifs located very
close to the TSS in the human PARG and IGHMBP2
promoters are primarily required for the initiation of tran-
scription during TPA responses. Studies on the
transcriptional mechanisms regulated by the duplicated
GGAA motifs and binding factors may provide a new
strategy to artiﬁcially induce differentiation of leukemia or
cancer cells by introducing speciﬁc gene expression- and
suppression-vectors.
Identiﬁcation of the duplication of the GGAA motifs
near the most 50-upstream regions of the TPA-inducible
genes
It has been indicated that the GGAA motif is located in the
promoter regions of some human genes encoding inter-
leukin-2 receptor b-chain (IL-2Rb), Ets-2, stromelysin 1,
TCRa enhancer, TCRb enhancer, and NFAT-1 [13].
Mutation of the GGAA motif abolished activity of the
IL-2Rb promoter during the PMA response in Jurkat cells.
These observations, including ours that we reported in a
recent paper [10, 12], suggested a hypothesis that the
GGAA motif might be an essential transcription regulatory
element with a positive response to TPA-induced signals.
By analyzing the activities of various promoters of human
genes encoding DNA helicases, or repair-associated pro-
teins, it has been shown that the duplicated GGAA motifs
are located in the XPB, RTEL, and Rb1 promoters [14].
It has been reported that, during the macrophage-like
differentiation of HL-60 cells, Rb1 belongs to a group of
TPA-inducible late genes [4]. In addition, the expression
of the PARG and the IGHMBP2 genes shows a late
responding proﬁle, and the gene encoding the GA-binding
transcription factor, b subunit 2, is classiﬁed into the early
response group [4, 10, 11]. Multiple GGAA motifs are
contained in the promoter region of the human CD68 gene
that is widely regarded as a pan macrophage marker in
immunohistochemistry studies, and its expression is regu-
lated by Elf-1, PU.1, and IRF-4 [15]. These observations
suggested that duplications of the GGAA motifs are nec-
essary for the TPA-late response or macrophage-like
differentiated state of the cells. Therefore, DNA sequences
of the 50-upstream regions of 19 late response genes were
investigated and analyzed by a TF-SEARCH [4, 14]. As
summarized in Table 1, duplications of the GGAA motifs
are found in eight TATA-less promoters, including the
Rb1, CD31(PECAM1), IL1R1, IL1R2, IL1RAPL2, S100A3,
eIF3A, and ECM1 promoters. The 50-ﬂanking regions of
the INHBA and S6 kinase genes contain clusters of GGAA
motifs [14]. Interestingly, promoter regions of the IL1R1,
IL1R2, and IL1RAPL2 genes, which encode the IL1 signal
receptor or its associated proteins, have duplicated GGAA
(TTCC) motifs (Table 1), suggesting that these genes are
regulated by the IL1 signaling system. Although a single
GGAA motif is located very close to the TSS of the
PEA15, ANXA5, and RFC-1 genes, another six promoters,
including those of the LGALS3, PREP, CHST10, RFXAP,
P2Y5, and KCNMA1 genes, do not contain duplications of
the GGAA motifs within the 300-bp from the most 50-
upstream region of their cDNAs [14]. Except for the P2Y5
promoter, which contains TA-rich sequences with Oct-1
binding sites, these are comparatively rich in GC content
with GC-boxes. Therefore, Sp1 or GC-box binding proteins
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in HL-60 cells.
The duplicated GGAA motifs are located
in the promoter regions of interferon-inducible genes,
and interleukin, endocrine signal-associated genes
Multiple GGAA motifs are found in the promoter region of
the human (Table 1) and the mouse ITGA2B genes
encoding the megakaryocyte marker, CD41, that regulates
cell adhesion and platelet aggregation [16, 17]. It has been
indicated that the MAP kinase signaling pathway and
transcription factors such as Elk-1 and Ets play impor-
tant roles in megakaryocytic differentiation [16, 18].
Overlapping GGAA motifs are hidden in the interferon
(IFN)-stimulated response element (ISRE)-like sequence
that IRF-2 binds to and activates transcription of the
ITGA2B gene [19]. It has also been reported that IRF-2
drives megakaryocytic differentiation via activation of the
promoter of the TPOR gene encoding a thrombopoietin
receptor [20]. These observations imply that transcriptional
activation by the cis-acting effect of the duplicated GGAA
motifs plays an important role in the differentiation of
megakaryocytic cells as well as macrophage-like cells.
Moreover, it has been reported that the ISRE of the mouse
programmed death-1 (PDCD1) promoter contains dupli-
cation of the GGAA (TTCC) motifs and plays a role in the
response to IFN-a in macrophages [21]. The PDCD1 gene
encodes an immuno-regulatory receptor that belongs to the
CD28 family [22]. In addition, duplication of the GGAA
motifs is found in the interferon-responsible promoter
regions of the human interferon-stimulated gene 15
(ISG15) [23] and CD40 (TNFRSF5) gene that encodes TNF
receptor super family [24] (Table 1). Furthermore, the
GGAA motif is located in an IFN-c activated sequence in
the transporter of antigenic peptide-1 (TAP1) promoter
[25]. Analysis of transcripts in puriﬁed neutrophils from
active tuberclosis patients, compared with healthy controls,
showed that IFNs activate JAK/STAT signal cascade to
induce various gene expressions, including IRFs and vari-
ous interferon-inducible genes [26]. Within 500 bp
upstream from the TSS, the duplicated GGAA (TTCC)
motifs are found in 50-ﬂanking regions of the OAS1, OAS2,
OAS3, IFI6, IFI44, IFI44L, IFIH1, IFITM3, TAP1, GBP2,
STAT1, STAT2, CD274, CXCL10, IFIT5, and IRF7 genes.
Therefore, the duplicated GGAA motifs and/or the recog-
nizing factors might play a part in the regulation of those
gene expressions responding to the signals evoked by IFNs.
Recent study showed that IFN-c-producing macrophages,
which co-express CD68 molecule, are identiﬁed in 70% of
human melanomas [27]. Although not duplicated, putative
c-Ets binding motifs are found in the promoter region of
the IFNG gene, suggesting that GGAA motif binding fac-
tors may co-regulate the IFNG and the CD68 genes in
macrophages.
As described above, the duplicated GGAA motifs are
commonly found in the IL1R1, IL1R2, and IL1RAPL2 gene
promoter regions (Table 1). Also, the duplication of the
motifs is observed in the human IL-1b [28] (Table 1), IL-2
[29], and IL-2Rb [13] promoter regions. A recent study
showed that Elk-1 and SRF regulate ets motif containing
the ZC3H12A promoter with IL1 dependency, suggesting
that the IL1 signaling system could be sensitized via the
Table 1 Duplication of the GGAA motifs in various human promoters
Genes Sequence
IL-1b 50-GAAGCTTCCACCAATACTCTTTTCCCCTTTCCTTTAA-30
CD31 (PECAM-1) 50-CCTCAGGAAGGCCGGTCATTTCCTGAGG-30
IL1R1 50-TGTTCTTCCTTCCCCAGG-30
IL1R2 50-TCACATTCCTTCCTACGC-30
IL1RAPL2 50-CTCATTTCCAGGCGCCCTTCCCTCTT-30 (downstream of TSS)
S100A3 50-AGCAATTCCAGGAAGGGCTTCCCCTCC-30
eIF3A 50-GCTCCTTCCTTTCCGTCTC-30 (downstream of TSS)
ECM1 50-GTGGCTTCCAGAGGAGGAGCAGCTGGGACTGAGTCATGGCAGGAAGCTGA-30 (downstream of TSS)
Rb1 50-CGGGCGGAAGTGACGTTTTCCCGCGG-30
CD41 (ITGA2B) 50-AAGACTTCCTGTGGAGGAATCTGAAGGGAAGGAGG-30
PDCD1 50-ACAGTTTCCCTTCCGCTCA-30 (downstream of TSS)
ISG15 50-CCTCGGGAAAGGGAAACCGA-30
CD40 (TNFRSF5) 50-TTGTGGGAATGTTCTGGGGAAACTCC-30
The 50-upstream regions (300–500 bp upstream from TSS) of the human IL-1b- and TPA-inducible late responding genes [4] were retrieved from
the GRCh37 reference primary assembly sequence database and analyzed with the TF-SEARCH program (http://www.cbrc.
jp/research/db/TFSEARCH.html). Eight of the 20 ‘‘late responding’’ classiﬁed promoters contain duplicated or triplicated GGAA (TTCC)
motifs [4]. GGAA (TTCC) motifs in the IFN-inducible CD41, PDCD1, ISG15, and CD40 promoters are also shown
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the IL1R gene, IL7R gene expression could be regulated by
the duplicated GGAA motif. In mouse T cells, it has been
shown that GABP regulates transcription of the IL7R gene
[31]. It was shown that the expression of the IL7R (CD127)
is strongly correlated with that of the Ets-1 in human
peripheral T cells [32]. It could be caused by the presence
of the GGAA (TTCC) duplication, 50-CAGACTTCC
TGTTTCTGGAACTTGC-30 that is located near the TSS
of the human IL7R gene. Moreover, a recent study indi-
cated that the GABP transcription factor is also required for
TCR rearrangement [33].
The effect of Ets proteins on the endocrine system has
been investigated [34]. It was recently indicated that two
ets motifs located in the human insulin induced gene 2
(INSIG2) promoter play important roles in the response to
insulin through binding or activation of the transcription
factor, SAP1a [35]. Duplication of the GGAA motifs is
found in the intronic promoter region of the human Glu-
cose-dependent insulinotoropic polypeptide-encoding gene
GIP [36]. The GIP can stimulate insulin release from
pancreatic b-cells when blood glucose concentration
increased [36]. These lines of evidence suggest that the
GGAA motifs regulate the expression of genes encoding
proteins that are involved in not only cellular differentia-
tion but also in the immuno response and endocrine
systems.
The GGAA-microsatellite-containing genes
in the human genome: the main target sequences
for EWS/FLI to function as an oncoprotein
Repetitive sequences are known to be located in eukaryotic
chromosomes. Telomeres, which are composed of TTA
GGG repeats, are located at the end of linear chromosomes
[37]. The centromere is a speciﬁc structural domain of the
chromosome with important functions to segregate chro-
mosomes accurately, and many protein components of the
centromere have been identiﬁed [38]. A centromere protein
(CENP) B box, which is recognized by CENP-B, is a 17-bp
motif containing GGAA and it appears within everyother a-
satellite repeat (171-bp) in human chromosomes [39, 40].
Those repetitive sequences are generally referred as micro-
satellites. Ewing’s sarcoma is a tumor in which Ets family
members are involved in chromosomal translocations [41].
The chromosomal translocation, t(11;22)(q24;q12) in the
malignant solid tumor generates the EWS/FLI oncoprotein
that functions as an aberrant transcription factor [42]. The
EWS/FLI oncoprotein is known to up-regulate the expres-
sion of various genes, including TGFb RII, cyclin D1, Id2
and c-Myc, IGFBP3, PTPL1, cyclin E, MK-STYX, and
caveolin1, through interaction with several ets (GGAA)
motifs [43]. The repetitive GGAA motifs are known as
GGAA-containingmicrosatellitesthatcanbetargetedbythe
oncoprotein EWS/FLI [42, 44]. The GGAA-containing
microsatellites are located in the promoter regions of
the DAX1/NR0B1, FCGRT, CAV1, CACNB2, FEZF1,
KIAA1797, and GSTM4 genes [43, 45, 46]. Recent study
suggested that EWS/FLI binds to these elements as a
homodimer to activate transcription [47]. The GGAA-
microsatellite is preferentially recognized and activated by
EWS/FLI but not by Ets1 and Elk1, suggesting that tran-
scription of genes containing GGAA-microsatellites is not
usually regulated by Ets family proteins [47, 48].
Identiﬁcation of the duplicated GGAA motifs
in the 50-ﬂanking regions of various human genes
By performing transfection experiments with mutation-
carrying reporter plasmids, we have indicated previously
that the duplicated GGAA motifs in the 50-ﬂanking regions
of the PARG, IGHMBP2, ATR, XPB, RTEL, and Rb1
promoters have essential roles in regulating the activities of
these promoters [10, 12, 14]. Comparing these duplicated
GGAA motifs, we have tentatively determined the con-
sensus 14-bp sequence as 50-(A/G/C)N(A/G/C)(C/G)(C/
G)GGAA(A/G)(C/T)(G/C/T)(A/G/C)(A/G/C)-30 [14]. The
probability of this combination occurring by chance can be
roughly estimated as only once in 8,630 combinations of
these bases, including the reverse orientation. The proba-
bility that the consensus 14-bp sequence would be
duplicated by chance within the 50-bp distance would be
extremely rare. Therefore, we explored the duplicated
14-bp sequences 2,000 bp upstream and 200 bp down-
stream of the TSS of 47,553 human genes extracted from
the Ensembl database. The computer-based in silico anal-
ysis retrieved 469 examples with one or more duplications
of the 14-bp sequence, including 234 instances of protein-
encoding genes of known function or structure. Eighty
percent (372/469) of the genes having consensus 14-bp
sequence lacks TATA-box, and 74% (345/469) of that have
GGAA(TTCC) duplications within 500 bp upstream
(Fig. 1). Although not all the 50-ﬂanking regions of those
function-known 234 genes contain the duplicated GGAA
motifs within a 450-bp distance of the TSS, 174 gene
promoters were found to have at least one duplicated
(overlapped) GGAA motif around the TSS (Table 2, Group
A). They include, for example, IFITM5, RBBP5, GRB2,
and SUMO1, encoding for the interferon-induced trans-
membrane protein 5/Bril [49], Rb-binding protein 5 [50],
growth factor receptor-bound protein 2 [51], and small
ubiquitin-modiﬁer 1 [52], respectively. The genes encoding
non-degradative ubiquitin signaling factors FANCD2,
which is suggested to regulate DNA replication and repair
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our search could not retrieve the 50-ﬂanking region of the
BRCA1 gene, the duplicated GGAA motifs are also
involved in the UP site and Ets2 binding site of the human
BRCA1 promoter [54, 55]. Ets2 binds to the 150-bp region
upstream of the UP site that is recognized by the GABP
transcription factor [54]. A tumor suppressor BRCA1,
which regulates DNA damage response, including cell
cycle check point control and DNA repair [56], has ubiq-
uitin E3 ligase activity [53, 57]. FANCD2, which is
involved in the Fanconi anaemia pathway [53], is mo-
noubiquitylated to form Fanconi anaemia core complex
with FANCI [56, 58]. Interestingly, OTUB1, which
encodes OUT domain-ubiquitin aldehyde binding 1, is
included in Table 2. Recent study indicated that OTUB1 is
an inhibitor of the DNA damage response that suppresses
poly- but not mono-ubiquitination [59]. These observations
suggest that the duplicated GGAA motifs control expres-
sion of genes encoding non-degradative ubiquitylation-
associated proteins. Other examples are promoter regions
of genes encoding TNF-associated signal proteins such as
TRAF1, TNFSF12 (TWEAK), and TNFSF13 (APRIL) [60–
62]. The expression pattern of the TRAF1 gene in HL-60
cells after TPA treatment has led to its classiﬁcation as an
intermediate responding gene [4]. It should be noted that
the GGAA motif is duplicated in the human TNF promoter
region [63]. Therefore, duplicated GGAA motifs could
regulate expression of the genes encoding proteins that are
associated with the TNF signal cascade. Moreover, several
promoters of glucose metabolism associated genes (G6PD,
GYS1, and SLC2A13) have been identiﬁed to contain the
duplication within the 450 bp upstream of the TSS [64–
66]. Although, the algorithm used in this study could not
acquire NR1H2 (LXRB) gene that was shown to be regu-
lated by Elk1 and SRF transcription factors [67], multiple
GGAA (TTCC) motifs are found around the TSS of the
NR1H2 promoter, suggesting that the duplicated (multiple)
GGAAs might also control glucose metabolism in cells.
The tandemly repeated GGAA motifs are found in the
long terminal repeat of the HIV2 gene [68] and that have
been identiﬁed as essential sequences in the human FcRc
promoter [69]. The locations of the ets elements in various
viral gene, Fc receptor and immunoglobulin, and other
promoters were reviewed previously [70]. Redundancy or
overlapping of the GGAA motifs in TP53, PF4 (Platelet
Factor 4), and UTRN (Utrophin) promoters has been
indicated [70]. These observations suggest that overlapped
or tandem repeated GGAA motifs are contained in pro-
moter regions of various genes that encode biologically
important protein factors.
Distribution of the Ets binding motifs in the whole
human genome
A recent study using promoter chromatin immunoprecipi-
tation (ChIP) microarray analysis to search for Ets family
protein binding regions in the human genome indicated that
promoters occupied by Ets1, ELF1, or GABPa were fre-
quently bound by one or more of the other Ets proteins
[48]. Quantitative ChIP analysis indicated redundant
binding of these transcription factors to the promoter
regions of the COX17 and DFFA genes that are listed in
Table 2 [48]. Moreover, BTRC (Table 2) promoter was
shown to be Ets1-RUNX1 co-occupied as TCRa and TCRb
promoters [48]. Thus, the genome-wide promoter ChIP
analysis indicated that 5–15% of the 17,000 human pro-
moters are redundantly occupied by these Ets proteins.
Bioinformatic studies have also indicated that Ets-like
binding sites are over-represented in human promoters
[71–73]. Our in silico search analysis retrieved 195
(Table 2, Group A and B combined) genes that represent
only 1% of total genes. This unexpectedly low value may
be resulted from somewhat stringent condition for the ﬁrst
screening to ﬁnd duplications of the PARG/IGHMBP2
Fig. 1 Most of the 50-upstream regions having duplicated GGAA
motifs are TATA-less. a The number of genes that have duplicated
GGAA consensus 14-bp sequence [14] in the 2,000 bp upstream from
TSS was 469. Among them, 372 genes have no TATA-box within
500 bp upstream. b The number of genes that have duplicated GGAA
consensus 14-bp sequencein the 2,000 bp upstream and GGAA
(TTCC) overlapping within 500 bp upstream of TSS was 345. Among
them, 279 genes have no TATA-box within 500 bp upstream.
Numbers of genes from the Ensemble database are shown
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protein has preferential ﬂanking sequence of the GGAA
(TTCC), our selected 14-bp might have restricted candidate
genes. Recently, overlap between ChIP-seq peak data
indicated several preferential combinations of the Ets
family proteins that depend on cell lines used [74]. The
occupancy of Ets proteins in the same promoter region
could be explained by alternative binding of the Ets pro-
teins on the same binding site [48]. Another explanation is
that there is a separate binding site containing duplicated or
overlapped GGAA (TTCC) motifs for each factor around
the TSS.
Biological properties of the Ets family proteins—
functions as proto-oncogene products
An oncogene, v-ets, was identiﬁed from the E26 avian
leukemia virus in 1983 and a large family of conserved
genes were isolated [75, 76]. Several of them were targeted
by homologous recombination, and it has been demon-
strated that ets genes play important roles in embryogenesis
and hematopoiesis [75, 77]. The amino acid sequences of
the human Ets domains were aligned and their binding
sequences have been evaluated [48]. The Ets family pro-
teins not only have similarity in amino acid sequences (Ets
domains) but also have similarity in their recognizing DNA
sequences [48]. It has been reported that the Ets tran-
scription factor, ER81, stimulates hTERT gene expression
[78, 79]. A recent study indicated that the hTERT promoter
possesses two biologically important Ets motifs (EtsA and
EtsB) and that Ets2 maintains hTERT gene expression in
cooperation with c-Myc in breast cancer cells [80]. It is
noteworthy that the TTCC motif-overlapped EtsB
sequence, 50-TTCCTTTCC-30, which is the same as the
one located in the eIF3A promoter (Table 1), is found close
to the TSS of the hTERT gene. Analyzing sequences of the
hTERT promoter from non-small cell lung cancers revealed
that mutations of the TTCC motif correlate with low levels
of telomerase activity and short telomeres [81]. It should
also be noted that palindromic Ets-binding sites are located
in the promoter region of the human TP53 gene and that
Ets1 binds to the sequence [70, 82]. The biological rele-
vance of Ets1 to transcriptional activity of the TP53
Table 2 Human promoter regions containing duplication of the GGAA motifs near the TSS
Group A Group B
AAGAB CPSF7 FAM72D HSPA5 OBP2A RBBP5 SPATA2 USP32 ANAPC2
ACAA1 CRTC1 FAM76B HSPA8 OTUB1 RBM33 SPTAN1 VPS53 ARMC10
ACOX3 CXCL17 FAM89A IFITM5 OXT RBM34 SRP19 WDFY3 CCNK
AEN CYB561 FAM126B IRF2BP1 PAFAH1B3 RDBP SSNA1 WDR27 CIA01
AFAP1L2 DAPK3 FAM153A ITGB3BP PDGFRB R3HDM2 SUMO1 WDR87 CNST
AGBL5 DCAF5 FASN KBTBD4 PEX6 RPAP1 SYNGAP1 YRDC CRYAB
AKAP10 DDA1 FBXL6 KCNG4 PEX14 RSL1D1 TFB2 M ZBTB17 EFCAB7
AKT3 DEAF1 FBXL13 KCNJ2 PGAP1 RSL1D1 TFDP2 ZBTB32 FANCD2
ALDH3B1 DEC1 FBXW2 KTI12 PHOX2B RXFP4 TMEM127 ZBTB45 IQCH
APITD1 DEFA1 FCHSD2 MAPKAP1 PIGM SDHB TMEM161A ZC3H13 LAMB2
ARHGAP1 DEFA1B FIBP MCM3AP PITX3 SDK2 TOMM20 ZNF252 MRPL32
ARMC7 DEFA3 FIZ1 MED8 PLLP SENP1 TNFSF12 ZNF343 NDUFB3
BTRC DFFA GDPD2 MEX3A POLD4 SETD3 TRAF1 ZNF443 NDUFS3
CCDC79 DIS3 GOLGA3 MGAT4B POLR2L SF3A1 TRPM3 ZNF555 NUDT22
CCT6A DPAGT1 G6PD MUT PRELP SF3B2 TRPT1 ZNF558 ODF3B
CELA3B DUX4 GPR155 MYBBP1A P2RY14 SFRS4 TTC16 ZNF628 PDCD1
CFL1 EDC3 GRB2 NARS PSMA2 SLC2A13 TTLL8 ZNF669 PSPH
CHMP1A ELAC2 GYS1 NBPF11 PSMB1 SLC3A2 TYMP ZNF782 SDHAF2
CIDECP ERO1L HAS2 NCAPG2 PSME1 SLC10A4 UBE2MP1 ZNF828 TSPAN4
C1QTNF6 ETFA HCFC1 NOC2L PURB SLC35F2 UBXN1 ZSCAN29 VPS52
CORT FAM49B HDHD2 NT5C RAB27A SLMO2 USP19 ZNF408
COX17 FAM70B HERC4 NUP155 RABL5 SMUG1 USP28
174 genes 21 genes
Group A The tentatively deﬁned TPA-activation consensus 14-bp sequence, 50-(A/G/C)N(A/G/C)(C/G)(C/G)GGAA(A/G)(C/T)(G/C/T)(A/G/
C)(A/G/C)-30, was searched in the Ensembl data base. Duplicated or overlapped GGAA motifs were identiﬁed near the most 50-upstream of those
174 genes. Group B Twenty-one genes were found to be head–head linked with genes listed in Group A
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123promoter has been shown in embryonic stem cells under-
going apoptosis induced by UV irradiation [83]. A recent
study indicated that the nuclear apoptosis-enhancing
nuclease encoding AEN gene is a target of p53 [84]. It has
been reported that the death-activated protein kinase
(DAPK) family modiﬁes MDM2 and p21 proteins [85].
The AEN and DAPK3 promoters were identiﬁed by our
search algorithm (Table 2), suggesting that genes encoding
p53 and its associated proteins are commonly regulated by
the duplicated GGAA motifs at the transcriptional level.
Furthermore, palindromic Ets binding sites in the CRYAB
(alphaB-crystallin) gene promoter are positively regulated
by Ets1 in breast cancer cells [86]. The epithelium-speciﬁc
Ets transcription factor, ESE-1, which is abundantly
expressed in human breast cancer, has been reported to
have transforming activity in MCF-12A human mammary
epithelial cells [87]. Recently, it was shown that the Ets
family member ETV1 works as a regulator of gastroin-
testinal stromal tumors in combination with oncogene
product KIT protein [88]. Whole genome sequencing
analysis of human prostate cancer suggested that
TMPRSS2-ERG fusion protein generated by gene rear-
rangement causes aberrant transcription or chromatin
structure and that it is correlated with the tumorigenesis
[89]. As described above, the GGAA motifs are duplicated
in the human PARG promoter [10]. It should be noted that
the duplicated GGAA motifs are located in the promoter
region of the human PARP-1 [90] and p21 [91] genes,
which encode poly (ADP-ribose) synthetase and Cdk
inhibitor, respectively. Taken together, these observations
suggest that Ets family proteins regulate cancer develop-
ment or tumorigenesis.
Apoptosis regulating functions of Ets family proteins
Apoptosis or programmed cell death is known to be reg-
ulated by various factors including caspases, DNases, or
signal transduction proteins [92]. The importance of Ets
family proteins in the regulation of cell-death has been
proposed [75]. Caspase-1 has been identiﬁed as ICE (IL-1b
converting enzyme), which plays a prominent role in
inﬂammatory responses [93, 94], and it is involved in the
regulation of apoptosis [95, 96]. Interestingly, it has been
demonstrated that caspase-1 is a direct target gene of Ets1
[97]. The caspase-1 gene is also up-regulated by PU.1 in
erythroleukemia cells undergoing apoptosis [98, 99]. The
activation of caspase-1 gene expression could be explained
by the presence of the Ets binding sequence located in the
promoter region [97]. Ets family proteins have been shown
to regulate apoptosis of endothelial cells [100, 101]. The
repeated GGAA motifs are located in the promoter region
of the human VE-cadherin gene and the Erg transcription
factor has been shown to bind to that sequence in a ChIP
assay [100, 102]. Expression of antiapoptotic genes,
including Bcl-XL and cIAP, is regulated by Ets1 and Ets2
during embryonic development [101]. In human mesothe-
lioma cells, Ets2 and PU.1 up-regulate Bcl-XL transcription
to prevent cells from undergoing apoptosis [103]. The
thioredoxin-binding protein 2 (TBP2) promoter, which
contains multiple ets motifs, is regulated by Ets1 in the
MG-63 osteosarcoma cell line [104]. TBP2 is thought to
cause apoptosis through activation of ASK1 and JNK
[105]. Moreover, the Ets1 binding site is present in the
proto-oncogene Pim-3 promoter [106]. Up-regulated Pim-3
gene expression caused by Ets1 is thought to prevent
apoptosis in cancer cells. Our search indicated that PARG/
IGHMBP2-like GGAA motifs are located in the promoter
regions of the PDCD-1 [22], and DFFA genes, encoding
inhibitor of caspase-activated DNase (ICAD) [107]. Fur-
thermore, the duplicated GGAA motifs are contained in the
human Bcl-2 [108], Fas (CD95) [109], and FasL [110]
promoter regions.
Taken together, Ets proteins could function as positive
and negative apoptosis regulators controlling expression of
the apoptosis signal transduction protein-encoding genes.
The duplicated GGAA sequence functions
as a fundamental transcription regulatory element
for TATA-less promoters
Molecular mechanisms of the initiation of transcription by
RNA-polymerase II (RNA pol II), which is involved in the
large protein complex in eukaryotic cells, have been well
studied [111]. Sequential complex formation occurs at
transcription initiation sites very close to the TATA-box
where the TATA-binding protein (TBP)/TFIID complex
binds ﬁrst, then TFIIA, TFIIB, RNA pol II-TFIIF, TFIIE,
and the DNA helicase TFIIH assemble to make a large
protein complex known as the transcription machinery
[112]. The very ﬁrst step of this RNA pol II-mediated
transcription-initiating reaction begins with the recognition
and binding of the TBP protein to the TATA-box. How-
ever, the TATA-box is not always found near the most
50-upstream region of the cDNA. It was reported that about
76% of human core promoters lack TATA-like element
[113]. Figure 1 shows that 81% (279/345) of the genes
having duplication or more GGAA consensus 14-bp
sequences [14] in the 2,000-bp upstream region contain
overlapped GGAA(TTCC) motifs within 500 bp upstream
and have no TATA-box. The promoters that have no
TATA-box near the TSS are usually known as TATA-less
promoters, and they have a high GC content and frequently
contain Sp1 binding sites, SCGGAAGY, or TGCGCANK
motifs [113]. If the general transcription factors need to be
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123recruited onto the TATA-less transcription initiation site,
other cis-acting sequences and binding protein factors are
required for the initiation of the transcription reaction in
mammalian cells.
It should be noted that the overlapping GGAA motif-
containing sequence, 50-CCTATGGAAACACAGGAAGT
GAC-30, is found in the TBP promoter region and the ets
motif has been shown to play an important part in regulation
of the promoter activity [114]. Quantitative PCR-ChIP
analysis indicated speciﬁc binding of ELK1 to the TBP,
TAF1, TAF7, TAF12, GTF2A1, GTF2B, and BTAF1 pro-
moters [115]. Moreover, it has been reported that the
epithelium-restricted Ets transcription factor, ESX binds to
TBP, and that the ETS family transcription factor, ERM,
interacts with TAFII40 and TAFII60 as well as TBP [116,
117].Furthermore,ithasbeenshownthatPU.1playsarolein
recruiting the TBP/TFIID complex to the defensin-1 pro-
moter around the TSS [118]. It should also be noted that
Defensin a1 protein is encoded by the genes DEFA1 and
DEFA1B whose promoters locate tandem repeat GGAA
motifs [118] as listed in Table 2. These lines of evidence
suggest that the ETS family proteins not only directly affect
transcription of the TBP and its associated protein-encoding
genes,butalsoguide general transcriptionfactors, including
TBP, towards the TSS of the duplicated GGAA motif-har-
boring promoters. Recently, the crystal structure of Elf3,
whichisamemberoftheEtsfamilyofproteins,wasrevealed
tobindtoGGAAmotifsofA-andB-sitesofthetypeIITGF-
b receptor (TGF-b RII) promoter, and it was concluded that
regions ﬂanking the Ets domain are essential for DNA
binding [119]. The presented model describing binding of
the Elf3 with A- and B-sites in the TGF-b RII promoter
region suggests that the duplication of the GGAA motifs
might give a scaffold for general transcription factors near
the TSS. In other words, tandemly repeated GGAA motifs
might give rise to a fundamental position for the pre-initia-
tion complex to bind around the TSS without TATA-box
like sequences. The overlapped GGAA motifs may have
advantages to control transcription precisely only by the
expressionlevelsoftheEtsfamilymembersaccordingtothe
behavior of cells to proliferate, differentiate, undergo
apoptosis, or respond to IFN-induced signals (Fig. 2).
Therefore, it could be happening that the promoter of the
same gene is active in speciﬁc cells while it is attenuated in
other cells depending on the GGAA-motif binding protein
expression proﬁles.
Co-operation of the GGAA motifs with other
transcription factor binding cis-elements near the TSS
As described above, duplicated GGAA (TTCC) motifs are
found in the promoter region of the human IL-1b gene
(Table 1). The IL-1b gene is synergistically regulated by
PU.1 and IRFs through their binding to the PU.1/IRF
composite element that is located -2.8 kb from the TSS
[120]. The GGAA motif and other transcription factor
binding site(s) can co-operatively affect promoter activity
of various genes. For example, Sp1 is a transcription factor
that binds to the GC boxes with the consensus sequence
50-(G/T)GGGCGG(G/A)(G/A)(C/T)-30 or 50-(G/T)(G/A)G
GCG(G/T)(G/A)(G/A)(C/T)-30 [121]. It has been reported
that both the GGAA motif and the Sp1-binding element
play important roles in regulating transcription of the
human VE-cadherin (CDH5) [102] and presenilin 1 (PS1)
genes [122]. Interactive regulatory function of the Sp1 and
Ets-1 has been observed in the promoter region of the
murine guanylyl cyclase/natriuretic peptide receptor-A-
encoding gene, Npr1 [123]. Moreover, GABP and Sp1 co-
operatively regulate human Heparanase1 (HPR1) promoter
activity [124] Oct-1, which is encoded by POU2F1 gene,
belongs to POU homeo-domain transcription factors [125].
Members of this family recognize and bind to the octa-
meric sequence ATGCAAAT to activate transcription of
Fig. 2 Hypothetical transcription controlling system in which dupli-
cated GGAA (TTCC) motifs and Ets family proteins are involved.
Closed circles represent GGAA (TTCC) motifs that are located near
the TSS. The transcription activity is indicated by the size of the
arrows. Multiple Ets family proteins, which are indicated by open
squares, closed squares, triangles, and diamonds, could be induced
by differentiation-inducing signals, apoptosis-inducing signals or
speciﬁc cytokines. Their redundant occupancy around the TSS can
regulate variable gene expression with subtle changes, depending on
the combinations of the binding proteins. The over-transcribed
mRNAs may be further regulated or ﬁne-tuned by micro RNAs
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123various genes [126]. Oct-1 and PU.1 is involved in the
control of the murine CD45 (Ptprc) promoter activity
[127]. Characterization of the promoter region of the Fi-
broleukin (FGL2) gene revealed that the cis-elements, Oct-
1, Ets1 and Sp1/Sp/3, co-operatively regulate its tran-
scription [128, 129]. Similarly, the human BTK gene
promoter, in which duplicated GGAA motif is located, is
regulated by binding of Sp1/Sp3, PU.1, and Oct-1 [130,
131]. Furthermore, c-Ets and the POU homeo-domain
transcription factor, GHF-1/Pit-1 enhances Ras/Raf to
activate the rat prolactin (PRL) promoter [132]. Recently,
it was shown that human prostacyclin receptor (PTGIR)
gene promoter is regulated by Sp1, PU.1, and Oct-1 ele-
ments, and a schematic model was presented to suggest
that Sp1-PU.1-Oct-1 ternary complex might recruit pre-
initiation complex, including TBP, TFIID, and RNA pol II,
to the TSS [133]. It has been shown that Ets1 and RUNX1
bind DNA co-operatively [48]. Recent genome-wide
analysis of human promoters revealed that Elk1 and Ets1
bound regions are frequently occupied with SRF [115], and
CBP [134], respectively. Moreover, it has been reported
that AP1 element is co-located with ETS binding site in the
promoter regions of several tumor invasion/metastasis-
associated protein-encoding genes, such as MMP-1/type I
collagenase, MMP-3/stromelysin, MMP-7/matrilysin, and
MMP-9/type IV collagenase genes [135]. Taken together,
these observations suggest that transcriptional initiation
may be co-regulated by the Ets family proteins in co-
operation with GC-box binding factors, POU homeo-
domain transcription factors, and other transcription factors
including RUNX1, SRF, CBP, and AP1 binding factors at
the region close to the TSS.
Conclusion
Duplication of the GGAA motifs is found within a 500-bp
distance of the TSS of various genes. Several of these
genes are classiﬁed as intermediate and late responding
genes during the macrophage-like differentiation of HL-60
cells induced by TPA. The duplicated GGAA motifs are
located in the promoter regions of genes encoding inter-
leukin-, interferon-, TNF-signal-associated proteins,
apoptotic factors, cancer-causing proteins, tumor suppres-
sors, or cell cycle controlling proteins including Rb and
p53. Almost all these promoters have no obvious TATA-
box, suggesting that the duplicated GGAA motifs play
important roles in precisely recruiting the pre-initiation
complex near the TSS. Redundant occupation of the
duplicated GGAA motifs by Ets family proteins seems to
be a complicated system, but this would enable ﬁnely tuned
regulation of each promoter through altering composition
of Ets family proteins or GGAA-binding proteins in the
nucleus in response to cellular signals (Fig. 2). Moreover,
it is noteworthy that the duplication of the GGAA motifs
contained in the 50-ﬂanking region of the human TBP gene
is essential for regulating promoter activity. To date, ini-
tiation of transcription is explained mainly by the binding
of TBP onto the TATA-box. Here, we propose an alter-
native transcription initiation mechanism where the
duplication of the GGAA motifs is primarily required for
determining the TSS in eukaryotic cells and for regulating
expression of various genes. Further investigations into the
regulatory mechanisms of the duplicated GGAA motif-
containing promoters will enable the development of a new
treatment for leukemia and malignant tumors by intro-
ducing Ets family protein expression vectors into cells.
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